Adverse effects of corticosteroids on the cardiovascular system.
about
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthaseInflammatory bowel disease: perioperative pharmacological considerations.Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.Is it cardiac involvement mimicking acute myocardial infarction in idiopathic inflammatory myopathy?Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study.Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.Comorbidity in inflammatory bowel disease.Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.Mechanisms of action of topical corticosteroids in psoriasisPremature Atherosclerotic Cardiovascular Disease in Childhood Cancer Survivors.Topical ocular dexamethasone decreases intraocular pressure and body weight in rats.Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary diseaseDrugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.9β Polymorphism of the glucocorticoid receptor gene appears to have limited impact in patients with Addison's disease.Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 yearsLow-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.Roflumilast: a green signal is yet to comeRole of BCL2-associated athanogene 1 in differential sensitivity of human endothelial cells to glucocorticoids.Using Systems Biology-based Analysis Approaches to Identify Mechanistically Significant Adverse Drug Reactions: Pulmonary Complications from Combined Use of Anti-TNFα Agents and Corticosteroids.Glucocorticoid treatment and cardiovascular disease.Niacin Ameliorates Lipid Disturbances due to Glucocorticoid Administration in Rats.Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate.Dexamethasone inhibits activation of monocytes/macrophages in a milieu rich in 27-oxygenated cholesterol.Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABAA Receptor Modulators.Molecular mechanisms of cardioprotective effects mediated by transplanted cardiac ckit+ cells through the activation of an inflammatory hypoxia-dependent reparative response.Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles.Increased risk of aortic aneurysm and dissection in patients with Sjögren's syndrome: a nationwide population-based cohort study in Taiwan
P2860
Q30439838-B90EFECA-22A8-40FE-B33C-88E46BB08F32Q30502980-D596C479-16AB-4F27-AE7E-DE1DAD22E947Q31000488-D781FB24-D447-4CFF-B574-11ED9ABEFD4AQ33633643-F6A33187-4331-4FBD-8FF1-79020FB23125Q33846894-59A7D524-D01E-4D79-BB8D-C2510913BFB1Q33926524-76E65B17-394A-4FA9-9282-0BC0691521B0Q34322559-B69AD36A-0854-4BCE-B8F6-CFE7C83AE32EQ35065318-D902842F-B14B-4E5B-853E-48CB0F3AF3ECQ35237977-F8464B96-748D-44B3-A10F-B736C1688B8EQ36429698-42A1C652-49BE-44A7-B7C9-26BB618DCE31Q36498620-6A173102-A25A-4D6D-B99D-580F5CBBA673Q36680477-30484742-8722-4866-8F40-257438DC751CQ36883464-899BBE44-A8B8-4EE6-9B96-4503CA6BA4B7Q37292191-2C3B7B4C-7115-4A5C-B15F-F642054D4391Q37422931-7CEC004D-F432-4F71-8B67-5EDB4D90A25FQ37510074-43DD4891-2653-46E0-B378-39B1AED9F37FQ37579933-8BC0502A-F051-4C1C-90F6-A4D954B97340Q37704498-65BC9553-E084-4E19-AC8C-1891CA2F1D6DQ38175951-9C06E03F-7E79-4567-9E11-36DF444F97DFQ41375399-750359EA-53A2-4B18-AC9E-19A216BEAE32Q42356932-690959B3-896F-4686-A751-7E21C751B00EQ42925553-43577AC0-39ED-48FF-BA6D-90D8D66E7643Q43013452-576056AB-5577-42FB-BBFC-854A582CEAA8Q43236608-0D3A56DE-60C8-4776-8EEC-9F3AF7503A35Q46790496-351E4D69-A2EB-4919-ACCF-C3273BAA1469Q47297664-EDA8993B-3EAE-403A-A113-C9FFB3B0B87FQ48235236-F4C431B6-E9C3-4F76-80FE-3AF1929B5D94Q50054706-A4CFE7B3-2973-4AE6-B286-3CAF762D3BF7Q55560176-51C79BD8-432A-472B-8E79-F6F678C82478Q58705095-D60137DF-1296-4CFC-AEC3-49E0B76AFC89
P2860
Adverse effects of corticosteroids on the cardiovascular system.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adverse effects of corticosteroids on the cardiovascular system.
@ast
Adverse effects of corticosteroids on the cardiovascular system.
@en
type
label
Adverse effects of corticosteroids on the cardiovascular system.
@ast
Adverse effects of corticosteroids on the cardiovascular system.
@en
prefLabel
Adverse effects of corticosteroids on the cardiovascular system.
@ast
Adverse effects of corticosteroids on the cardiovascular system.
@en
P1476
Adverse effects of corticosteroids on the cardiovascular system.
@en
P2093
Armstrong PW
Sholter DE
P304
P577
2000-04-01T00:00:00Z